An evaluation of the preoperative hemoglobin level as a prognostic factor for oral squamous cell carcinoma

Head and Neck Oncology

Volumn 3, Issue 1, 2011, Pages

  Cordella, Claudia ^a   Luebbers, Heinz Theo ^a   Rivelli, Valentina ^a   Grätz, Klaus W ^a   Kruse, Astrid L ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LOCAL METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH TUMOR; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREND STUDY; BLOOD; METABOLISM; MIDDLE AGED; PATHOLOGY;

ANEMIA; CARCINOMA, SQUAMOUS CELL; FEMALE; HEMOGLOBINS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 80051586714     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-3-35     Document Type: Article

References (33)

1. Cancer incidence and mortality in Europe, 2004. Boyle P, Ferlay J, Ann Oncol 2005 16 481 488 10.1093/annonc/mdi098 15718248 (Pubitemid 40458328)
2. Determinants of outcome following surgery for oral squamous cell carcinoma. Woolgar JA, Hall GL, Future Oncol 2009 5 51 61 10.2217/14796694.5.1. 51 19243298
3. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC, Br J Radiol 1953 26 638 648 10.1259/0007-1285-26-312-638 13106296
4. The effect of oxygen breathing and radiotherapy upon the tissue oxygen tension of some human tumours. Evans NTS, Naylor PFD, Br J Radiol 1963 36 418 425 10.1259/0007-1285-36-426-418
5. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Becker A, Stadler P, Lavey RS, Hansgen G, Kuhnt T, Lautenschlager C, Feldmann HJ, Molls M, Dunst J, Int J Radiat Oncol Biol Phys 2000 46 459 466 10.1016/S0360-3016(99)00384-3 10661354 (Pubitemid 30067797)
6. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Brizel DM, Dodge RK, Clough RW, Dewhirst MW, Radiother Oncol 1999 53 113 117 10.1016/S0167-8140(99)00102-4 10665787
7. Impact of hemoglobin levels on tumor oxygenation: the higher, the better? Vaupel P, Mayer A, Hockel M, Strahlenther Onkol 2006 182 63 71 10.1007/s00066-006-1543-7 16447012 (Pubitemid 43177190)
8. T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Warde P, O'Sullivan B, Bristow RG, Panzarella T, Keane TJ, Gullane PJ, Witterick IP, Payne D, Liu FF, McLean M, et al. Int J Radiat Oncol Biol Phys 1998 41 347 353 10.1016/S0360-3016(98)00062-5 9607350 (Pubitemid 28243546)
9. Tumor hypoxia and anemia: impact on the efficacy of radiation therapy. Kumar P, Semin Hematol 2000 37 4 8 11068949
10. Impact of anemia in patients with head and neck cancer. Kumar P, Oncologist 2000 5 Suppl 2 13 18 10896324 (Pubitemid 30413710)
11. Tumor anemia and thrombocytosis in patients with vulvar cancer. Hefler L, Mayerhofer K, Leibman B, Obermair A, Reinthaller A, Kainz C, Tempfer C, Tumour Biol 2000 21 309 314 10.1159/000030136 10940827 (Pubitemid 30666035)
12. Impact of pretreatment hematologic profile on survival of colorectal cancer patients. Qiu MZ, Yuan ZY, Luo HY, Ruan DY, Wang ZQ, Wang FH, Li YH, Xu RH, Tumour Biol 2010
13. The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target. Blancher C, Harris AL, Cancer Metastasis Rev 1998 17 187 194 10.1023/A:1006002419244 9770115 (Pubitemid 28391953)
14. Perioperative transfusion, postoperative infection, and recurrence of head and neck cancer. Sturgis EM, Congdon DJ, Mather FJ, Miller RH, South Med J 1997 90 1217 1224 10.1097/00007611-199712000-00011 9404909 (Pubitemid 27528362)
15. Prognostic significance of perioperative blood transfusion in oral cavity squamous cell carcinoma. Taniguchi Y, Okura M, Head Neck 2003 25 931 936 10.1002/hed.10313 14603453 (Pubitemid 37323008)
16. Prognostic impact of blood transfusion in patients undergoing primary surgery and free-flap reconstruction for oral squamous cell carcinoma. Fenner M, Vairaktaris E, Nkenke E, Weisbach V, Neukam FW, Radespiel-Troger M, Cancer 2009 115 1481 1488 10.1002/cncr.24132 19224554
17. The effect of perioperative blood transfusion on survival in head and neck cancer. Schuller DE, Scott C, Wilson KM, Freer R, al-Sarraf M, Jacobs J, Ahmad K, Casiano R, Laramore G, Arch Otolaryngol Head Neck Surg 1994 120 711 716 8018322 (Pubitemid 24217583)
18. Perioperative blood transfusion does not promote recurrence and death after mastectomy for breast cancer. Akyol AM, Galloway DJ, George WD, Br J Surg 1992 79 470 1596735
19. Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study. Donohue JH, Williams S, Cha S, Windschitl HE, Witzig TE, Nelson H, Fitzgibbons RJ Jr, Wieand HS, Moertel CG, J Clin Oncol 1995 13 1671 1678 7602357
20. Blood transfusion and tumour growth: evidence from laboratory animals. Francis DM, Shenton BK, Lancet 1981 2 871 6116980 (Pubitemid 11017580)
21. Blood product transfusion and cancer prognosis. Upile T, Jerjes W, Mahil J, Sudhoff H, Hopper C, Wright A, Clin Adv Hematol Oncol 2009 7 656 661 20040905
22. An explanation for the worsened prognosis in some cancer patients of perioperative transfusion: the time-dependent release of biologically active growth factors from stored blood products. Upile T, Jerjes W, Mahil J, Upile N, Sudhoff H, Wright A, Hopper C, European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies 2011
23. The direct effects of stored blood products may worsen prognosis of cancer patients; shall we transfuse or not? An explanation of the adverse oncological consequences of blood product transfusion with a testable hypothesis driven experimental research protocol. Upile T, Jerjes W, Sandison A, Singh S, Rhys-Evans P, Sudhoff H, Hopper C, Medical hypotheses 2008 71 489 492 10.1016/j.mehy.2008.04.027 18590945
24. Influence of blood transfusion on recurrence, survival and postoperative infections of laryngeal cancer. Bock M, Grevers G, Koblitz M, Heim MU, Mempel W, Acta Otolaryngol 1990 110 155 160 10.3109/00016489009122531 2386031 (Pubitemid 20206998)
25. Blood transfusion and other risk factors for recurrence of cancer of the head and neck. Jones KR, Weissler MC, Arch Otolaryngol Head Neck Surg 1990 116 304 309 2306348 (Pubitemid 20100604)
26. Blood transfusion and survival after laryngectomy for laryngeal carcinoma. Ell SR, Stell PM, J Laryngol Otol 1991 105 293 294 2026944
27. Effect of blood transfusion on recurrence of head and neck carcinoma. Retrospective review and meta-analysis. Woolley AL, Hogikyan ND, Gates GA, Haughey BH, Schechtman KB, Goldenberg JL, Ann Otol Rhinol Laryngol 1992 101 724 730 1387516
28. Transfusion, recurrence, and infection in head and neck cancer surgery. von Doersten P, Cruz RM, Selby JV, Hilsinger RL Jr, Otolaryngol Head Neck Surg 1992 106 60 67 1734370
29. Blood transfusion and other prognostic variables in the survival of patients with cancer of the head and neck. Barra S, Barzan L, Maione A, Cadelano A, Pin M, Franceschi S, Comoretto R, Laryngoscope 1994 104 95 98 8295465 (Pubitemid 24028043)
30. Blood transfusion and laryngeal cancer. Alun-Jones T, Clarke PJ, Morrissey S, Hill J, Clin Otolaryngol Allied Sci 1991 16 240 244 10.1111/j.1365-2273.1991.tb00921.x 1879064
31. Blood transfusions in laryngeal cancer: effect on prognosis. Leon X, Quer M, Luz Maestre M, Burgues J, Muniz E, Madoz P, Head Neck 1996 18 218 224 10.1002/(SICI)1097-0347(199605/06)18:3<218::AID-HED2>3.0.CO;2-2 8860761 (Pubitemid 26124032)
32. Autologous and heterologous blood transfusion in head and neck cancer surgery. Moir MS, Samy RN, Hanasono MM, Terris DJ, Arch Otolaryngol Head Neck Surg 1999 125 864 868 10448732 (Pubitemid 29372805)
33. The influence of allogenic blood transfusion in patients having free-flap primary surgery for oral and oropharyngeal squamous cell carcinoma. Szakmany T, Dodd M, Dempsey GA, Lowe D, Brown JS, Vaughan ED, Rogers SN, Br J Cancer 2006 94 647 653 10.1038/sj.bjc.6603013 16523195 (Pubitemid 43361895)